Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned of the potential danger of vision loss. In statements, Novo Nordisk says, in part, they are “vigorously” fighting the lawsuits, saying they are “without merit,” while Eli Lilly says in part, it maintains “patient safety” is its “top priority.” NBC News’ Stephanie Gosk has the story.
For more context and news coverage of the most important stories of our day, click here:
Every day, NBC News helps people understand what’s happening and why it matters — through fact-based reporting, meaningful conversations, and powerful stories. From its leading news broadcasts — TODAY, NBC Nightly News, Meet the Press, and Dateline — to NBC News NOW, the 24/7 streaming news channel, plus chart-topping podcasts, the NBC News app, and NBCNews.com, NBC News keeps audiences informed and connected to the stories shaping our world.
NBC News. Reporting for America.
» Subscribe to NBC News:
» Subscribe to Here’s the Scoop podcast:
» NBC News App:
» Breaking News Alerts:
» Visit NBCNews.Com:
» Find NBC News on Facebook:
» Follow NBC News on Twitter:
» Follow NBC News on Instagram:
#news #medicine #glp1
source
